Treatment Options for Occipital Neuralgia

Introduction to Treatment Options

The Congress of Neurological Surgeons recommends occipital nerve stimulation (ONS) as an effective treatment option for patients with medically refractory occipital neuralgia when conservative treatments fail 1

Ibuprofen (400 mg) or acetaminophen (1000 mg) are suggested for short-term pain relief by the American College of Physicians 2
Greater occipital nerve blocks are recommended for short-term treatment of occipital neuralgia by the American College of Physicians 2

The Congress of Neurological Surgeons gives a Level III recommendation for occipital nerve stimulation (ONS) for medically refractory occipital neuralgia 3, 1
ONS remains a viable treatment option for patients with medically refractory occipital neuralgia, with advantages including being reversible with minimal side effects and showing continued efficacy with long-term follow-up 1, 3
Common complications of ONS include lead migration (9-24% of cases) and infection 4, 5

There is insufficient evidence to recommend for or against using occipital nerve blocks to predict response to ONS by the Congress of Neurological Surgeons 4
When considering ONS, patients should undergo a trial stimulation period before permanent implantation to assess efficacy by the Congress of Neurological Surgeons 6

The Congress of Neurological Surgeons gives a Level III recommendation for occipital nerve stimulation (ONS) for medically refractory occipital neuralgia 7, 8
There is insufficient evidence to recommend for or against using occipital nerve blocks to predict response to ONS 9

Multiple wireless peripheral nerve stimulation systems have recently received FDA approval for pain treatment, with one device receiving expanded indication for headache and axial neck pain 10
The overall level of evidence for ONS remains low due to the lack of commercially available dedicated craniofacial PNS devices and limited insurance coverage 10

When occipital neuralgia becomes medically refractory, consultation with a neurosurgeon is recommended for consideration of occipital nerve stimulation (ONS), as suggested by the Congress of Neurological Surgeons with a Level III recommendation 11, 12, 13

The Congress of Neurological Surgeons provides a Level III recommendation for ONS as a treatment option for patients with medically refractory occipital neuralgia 13, 12
Wireless peripheral nerve stimulation systems have recently received FDA approval for patients who don't respond to conventional treatments, though insurance coverage may be limited 12

The Guideline Task Force for occipital neuralgia treatment consists of both neurosurgeons and pain management physicians, highlighting the importance of multidisciplinary care 13
For patients requiring ONS, ongoing management may involve both the neurosurgeon and pain specialist 12